Vieira, D.; Durães, J.; Baldeiras, I.; Santiago, B.; Duro, D.; Lima, M.; Leitão, M.J.; Tábuas-Pereira, M.; Santana, I.
Lower CSF Amyloid-Beta1–42 Predicts a Higher Mortality Rate in Frontotemporal Dementia. Diagnostics 2019, 9, 162.
https://doi.org/10.3390/diagnostics9040162
AMA Style
Vieira D, Durães J, Baldeiras I, Santiago B, Duro D, Lima M, Leitão MJ, Tábuas-Pereira M, Santana I.
Lower CSF Amyloid-Beta1–42 Predicts a Higher Mortality Rate in Frontotemporal Dementia. Diagnostics. 2019; 9(4):162.
https://doi.org/10.3390/diagnostics9040162
Chicago/Turabian Style
Vieira, Daniela, João Durães, Inês Baldeiras, Beatriz Santiago, Diana Duro, Marisa Lima, Maria João Leitão, Miguel Tábuas-Pereira, and Isabel Santana.
2019. "Lower CSF Amyloid-Beta1–42 Predicts a Higher Mortality Rate in Frontotemporal Dementia" Diagnostics 9, no. 4: 162.
https://doi.org/10.3390/diagnostics9040162
APA Style
Vieira, D., Durães, J., Baldeiras, I., Santiago, B., Duro, D., Lima, M., Leitão, M. J., Tábuas-Pereira, M., & Santana, I.
(2019). Lower CSF Amyloid-Beta1–42 Predicts a Higher Mortality Rate in Frontotemporal Dementia. Diagnostics, 9(4), 162.
https://doi.org/10.3390/diagnostics9040162